US Medical Innovations (USMI), a Biomedical and Life Science subsidiary of US Patent Innovations, has received the US Food and Drug Administration (FDA) approval for Canady Flex RoboWrist, its new robotic surgery device for open and laparoscopic procedures.
The Canady Flex RoboWrist (Flex RoboWrist) is a fully articulating motorised, hand-held surgical instrument that comes with a hook, scissors, needle driver, and dissector to provide three degrees of freedom and 360 degrees of rotation.
The device features a connector for the USMI XL-1000 electrosurgical generator, which facilitates the option of using the mono scissors or hook for electrosurgery.
The Flex RoboWrist is primarily intended for dissection, transection, and suturing of tissue during open, endoscopic and minimally-invasive surgical procedures such as laparoscopic, urologic, gynecologic, general and thoracic surgeries.
USMI said that its robotic surgery device is already approved and being used in the Middle East, Europe, and Asia.
US Medical Innovations CEO Jerome Canady said: “The Flex RoboWrist represents a significant advancement in laparoscopic surgical technology and will empower surgeons to achieve exceptional results and redefine the possibilities of laparoscopic surgical procedures.
“The flexible design provides motorized control of two movements that are essential to accessing surgical sites and laparoscopic suturing: bidirectional deflection and unlimited rotation of the distal jaws of the instrument.”
Flex RoboWrist comes with advanced automation and intelligent control systems, which optimise surgical workflows, and saves crucial time in the operating room.
Its key features and benefits include superior precision, allowing surgeons to perform intricate procedures with utmost accuracy.
Surgeons can use the advanced robotic technology to ensure precise movements, reducing the risk of human error and enhance surgical outcomes.
Furthermore, Flex RoboWrist is also cost-effective, autoclavable up to 50 times and does not require the use of disposables, said the biomedical devices company.
